Skip to main content
. 2016 Jul 8;11(7):e0158513. doi: 10.1371/journal.pone.0158513

Fig 9. Delayed-type hypersensitivity test.

Fig 9

(a) and (b) Intradermal injection sites. (c), (d) and (e) Negative, EBM and SLM groups, respectively. No erythema or other irritation appearance formed in the challenge sites for the three groups. (f) Positive group: discrete or patchy erythema formed in the challenge sites.